In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change practice? Listen to find out.


Some of the abstracts discussed:

  • PARADIGM: https://meetings-api.hematology.org/api/abstract/vmpreview/296881
  • KMT2A Outcomes (MARROW Consortium and Othman, et al.): https://meetings-api.hematology.org/api/abstract/vmpreview/302582 and https://meetings-api.hematology.org/api/abstract/vmpreview/297333
  • CLIA +/- Ven: https://meetings-api.hematology.org/api/abstract/vmpreview/302047
  • FLT3i studies (and MRD): https://meetings-api.hematology.org/api/abstract/vmpreview/295719 and https://meetings-api.hematology.org/api/abstract/vmpreview/302699 and https://meetings-api.hematology.org/api/abstract/vmpreview/291322
  • ALL GIMEMA Trial (blin + ponatinib): https://meetings-api.hematology.org/api/abstract/vmpreview/296532
  • Menin inhibitor data


Podden och tillhörande omslagsbild på den här sidan tillhör Bernard Marini, Anthony Perissinotti, et al.. Innehållet i podden är skapat av Bernard Marini, Anthony Perissinotti, et al. och inte av, eller tillsammans med, Poddtoppen.